Prof. Dr. Ivy Chung is a distinguished pharmacology lecturer and researcher specialising in oncology, molecular pharmacology, and therapeutics. She has managed multimillion-dollar research funding and led interdisciplinary projects bridging academia, industry, and communities. With a keen interest in innovation and entrepreneurship, she founded Cytus Sdn Bhd, providing human tissues and cell products for R&D. Her work focuses on cancer research, exploring cellular interactions and developing new therapeutic strategies. Prof. Ivy has an extensive academic background, including postdoctoral research at Harvard, a PhD in pharmacology from SUNY Buffalo, and a bioengineering degree from Tokyo Institute of Technology.

1. Molecular Pharmacology and Endocrinology

2. Cancer Research and Therapeutics

3. Tumor Microenvironment and Drug Resistance

4. Inflammatory Mechanisms in Disease

5. Innovation and Entrepreneurship in Biomedical Research

6. Multidisciplinary Research Management

1. Postdoctoral Fellowship in Biomedical Sciences - Harvard University

2. PhD in Pharmacology - State University of New York, Buffalo

3. Bachelor of Engineering in Bioengineering - Tokyo Institute of Technology